State-resolved digital twin
A domain model and state gateway. Every model result, design decision and experimental outcome is written back to it.
Velocin’s design engine orchestrates deterministic models, ML-driven parameter sweeps, and Monte Carlo simulations through proprietary workflows, integrated third-party models, and plug-ins. Each result is written back to the digital twin, continuously updating the experimental memory.
A domain model and state gateway. Every model result, design decision and experimental outcome is written back to it.
Adaptive evidence weighting with Gaussian forgetting. The digital twin reads from and writes to it, so evidence is retained and built on.
Proprietary workflows, integrated third-party models, and plug-ins — for example Evo 2, AlphaFold and RL-guided diffusion.
Deterministic models, advanced ML parameter sweeps and Monte Carlo simulation generate, score and prioritize vaccine candidates across pathogens, together with the next experiments to run.
Individual models evolve. Velocin’s digital twin, design engine, and experimental memory retain and build on evidence across research cycles.
One integrated AI approach connects evidence, models, compute, and people.
Frontier LLMs deployed on Velocin’s infrastructure continuously scan literature, patents, and regulatory filings to surface patterns across the evidence base.
Evo 2 and comparable foundation models integrate into the proprietary system as governed components, not standalone sources of truth.
Deterministic modelling and classic ML handle narrow, high-value tasks, with register-resident SIMD optimization for high throughput at low compute cost.
Scientists use governed AI tools and a shared world-model as a routine, collaborative part of every research task.
Neither discipline is rare on its own. What is rare, and what our competitors lack, is holding both in one company. The wet lab produces evidence that cannot be bought.
Over 20 years of researching and building parametric information systems in finance, where uncertainty, provenance and compute cost decide outcomes. A state-resolved digital twin, in silico design engine, and adaptive experimental memory are the key AI technologies Velocin applies in parametric vaccine design.
Velocin’s protein-based vaccine innovation was born in a world-leading research group of enterovirus virus-like particle vaccines: over 15 years of research at Tampere University, 17 published articles and 22 person-years of proprietary protein-based vaccine technology.
The design system will turn prioritized candidates into rapidly updatable vaccines across pathogens, with no eggs and no live virus. A seasonal influenza vaccine takes about six months today; our system targets half that.
The platform starts with multivalent enterovirus vaccines, where no broadly protective vaccine is licensed in Western markets.